Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women

The Women’s Health Initiative trial found a modestly increased risk of invasive breast cancer with daily 0.625-mg conjugated equine estrogens plus 2.5-mg medroxyprogesterone acetate, with most evidence among women who had previously received postmenopausal hormone therapy. In comparison, observation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Prentice, Ross L., Chlebowski, Rowan T., Stefanick, Marcia L., Manson, JoAnn E., Pettinger, Mary, Hendrix, Susan L., Hubbell, F. Allan, Kooperberg, Charles, Kuller, Lewis H., Lane, Dorothy S., McTiernan, Anne, O’Sullivan, Mary Jo, Rossouw, Jacques E., Anderson, Garnet L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670848/
https://ncbi.nlm.nih.gov/pubmed/18372396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwn044
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados